The present study investigated factors that modify or affect arterial stiffness as assessed by brachial-ankle pulse wave velocity (baPWV) in the general population. Subjects had previously participated in a physical checkup program (n ¼ 911), and baPWV and urinary albumin and sodium excretion were also measured. Urine albumin was expressed as the ratio of urine albumin to urine creatinine. Individual salt intake was assessed by estimating 24-h urinary salt excretion and expressed as the ratio of estimated salt intake to body weight. The mean blood pressure and baPWV were 127.1±15.2/77.0±9.5 mm Hg and 15.9±3.3 m s À1 , respectively. Univariate analysis demonstrated that baPWV correlated with various factors including age, blood pressure, electrocardiogram voltage (SV 1 þ RV 5 ), urine albumin and salt intake. Multivariate regression analysis revealed that electrocardiogram voltage (Po0.001), systolic blood pressure (Po0.0001), urine albumin (Po0.001) and salt intake (Po0.001), independently correlated with baPWV after adjustment for other possible factors. Similar results were obtained for participants not taking any medication. These results suggest that the baPWV value is independently associated with individual salt intake and cardiac and renal damage, and could be a useful procedure for identifying individuals with concealed risk of cardiovascular disease.
INTRODUCTION
The increase in cardiovascular morbidity can be mitigated by assessing conventional cardiovascular disease risk factors. However, these assessments may not accurately estimate the risk of developing cardiovascular disease. Measurements of arterial function and structure provide additional prognostic information to conventional risk factors. 1 Indeed, aortic pulse wave velocity (PWV), an indicator of large artery stiffness, is a predictor of cardiovascular morbidity and mortality, independent of traditional risk factors in patients with hypertension and also in the general population. 1 --3 Age, hypertension and diabetes are the primary determinants of PWV. 4, 5 The recent European guidelines for the management of hypertension introduced increased PWV as an index of cardiovascular target organ damage and as a determinant to be taken into account in the evaluation of cardiovascular risk. 6 As PWV independently predicts cardiovascular morbidity and mortality, factors that accelerate the increase of PWV may be involved in the mechanisms underlying the pathogenesis of cardiovascular disorders. Therefore, assessment of these factors may be useful for identifying individuals at an increased risk of developing cardiovascular disease. Furthermore, intervention aiming to modify these factors may improve the prognosis of these individuals.
Recently, a semi-automated device for the measurement of brachial-ankle PWV (baPWV) was developed. 7 --9 The PWV value estimated by this device reflects a combination of elastic and muscular arterial stiffness. Hence, the clinical significance of baPWV may be different from that established by carotid-femoral PWV, a noninvasive index of central arterial stiffness. However, baPWV measurements show close correlations with aortic PWV measurements obtained using a catheter-tip manometer. 7 Due to its simplicity, the baPWV method would be suitable in the clinical setting. Thus, the present study was designed to investigate factors that modify or affect baPWV values in the general population.
SUBJECTS AND METHODS
This study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Ethics Committee of our hospital. All subjects gave written informed consent before participating in this study.
Subjects and study design
A cross-sectional study was conducted to investigate the clinical significance of baPWV in the general population. Apparently, healthy subjects who had participated in a health checkup program at our hospital between January 2009 and December 2009 were screened for eligibility to participate in the present study. In addition to the routine health checkup program (comprising a routine physical examination, chest X-ray, electrocardiography and laboratory assessment of cardiovascular risk factors), baPWV was measured using a semi-automated device (form PWV/ ankle or brachial systolic blood pressure index, BP-203RPE II; Omron Colin, Tokyo, Japan). Subjects with heart failure, valvular heart disease, atrial fibrillation and peripheral artery disease (an ankle/brachial systolic blood pressure index o0.95) were excluded. A total of 911 subjects were enrolled in this study, of which 46.9% were male. Blood pressure was measured using a standard mercury sphygmomanometer with the subject in the sitting position. Three consecutive blood pressure measurements were taken at 2-min intervals, and the mean of the second and third measurements was recorded as the blood pressure. Electrocardiograms were recorded after the participants had rested for 1 min in the supine position in an air-conditioned room. Subjects were defined as having hypertension if their systolic blood pressure X140 mm Hg, diastolic blood pressure X90 mm Hg, or used antihypertensive medications. Subjects were defined as having dyslipidemia if their high-density lipoproteincholesterol levels were o40 mg dl À1 , low-density lipoprotein (LDL)-cholesterol X140 mg dl
À1
, triglycerides X150 mg dl À1 , or they used anti-dyslipidemic medications. Subjects were defined as having diabetes mellitus if their fasting plasma glucose X126 mg dl À1 or they used antidiabetic medications. Cross-sectional analyses were performed to investigate relationships between baPWV values and other cardiovascular risk factors.
Biochemical measurements
Single-void morning urine samples were collected for the measurement of urinary albumin and sodium excretion. Urinary albumin was measured by a turbidimetric immunoassay, using an automated analyzer (JCA-BM8000, Japan Electron Optics Laboratory, Tokyo, Japan). The sensitivity limit for albumin was 1.1 mg l À1 ; values o1.1 mg l À1 were defined as 0. Urinary excretion of albumin was expressed as the ratio of urinary albumin to urinary creatinine (UACR; mg g À1 creatinine). Individual salt intake was assessed by estimating 24-h urinary salt excretion, which was calculated using a previously reported formula, 10 and expressed as the ratio of estimated salt intake to body weight (g per 10 kg body weight). Plasma B-type natriuretic peptide (BNP) levels were measured by radioimmunoassay (Shionoria BNP kit, Shionogi, Osaka, Japan).
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Statistical analysis Data were processed using the software package SPSS statistics 17.0 (SPSS, Tokyo, Japan). Data in the text and the tables are expressed as the mean ± s.d., except for BNP and UACR, which are expressed as median values. Levels of BNP and UACR were log-transformed before statistical analysis. Differences between two groups with a normal distribution were compared by unpaired Student's t-tests. Univariate and multivariate regression analyses were performed to examine the relationship between baPWV values and other factors. P-values less than 0.05 were considered statistically significant. Table 1 lists the baseline characteristics of all participants. Further analysis showed the following results. baPWV levels were significantly greater in men (16.3±3.6 m s À1 ) than in women (15.6 ± 3.0 m s À1 ; Po0.05). Some participants had hypertension (35.9%), diabetes mellitus (13.9%), or dyslipidemia (45.6%), and 41.6% of all participants were taking medication for these diseases. Urinary albumin was detected in 826 participants (90.7%), and 51 participants (5.6%) had microalbuminuria (UACRX30 mg per g creatinine).
RESULTS
Univariate analysis revealed that the baPWV value was correlated with various factors including age, gender, blood pressure, heart rate, serum creatinine, uric acid, fasting plasma glucose, high-density lipoprotein-cholesterol, LDL-cholesterol, triglycerides, electrocardiogram (ECG) voltage (SV 1 þ RV 5 ), UACR, BNP and estimated salt intake adjusted for body weight (Table 2 and Figure 1 ). Multivariate regression analysis revealed that systolic blood pressure, ECG voltage, UACR and estimated salt intake were independently correlated with baPWV after adjustment for age, gender, heart rate, serum creatinine, uric acid, fasting plasma glucose, high-density lipoprotein-cholesterol, LDL-cholesterol and BNP (Table 3) . To confirm the clinical significance of baPWV, similar analyses were performed in a subgroup of participants who were not taking any medication. In non-medicated subjects (n ¼ 531), baPWV was independently correlated with systolic blood pressure (standardized coefficient 0.303; Po0.0001), UACR (0.082; P ¼ 0.01), estimated salt intake (0.137; P ¼ 0.0002), age (0.448; Po0.0001), heart rate (0.160; Po0.0001) and uric acid (0.134; P ¼ 0.001), but not with ECG voltage (0.058; P ¼ 0.09), after adjustment for gender, serum creatinine, fasting plasma glucose, high-density lipoproteincholesterol, LDL-cholesterol and BNP (R 2 ¼ 0.509; Po0.0001).
DISCUSSION
The present study demonstrated that the baPWV value measured using a semi-automated device provides useful information for evaluating individual cardiovascular risk in the general population. As baPWV reflects not only blood pressure levels, but is also an index of hypertensive organ damage, the measurement of baPWV may be an important new procedure for the risk evaluation and management of individuals with a low to moderate risk of cardiovascular disease. Abbreviations: baPWV, brachial-ankle pulse wave velocity; BNP, B-type natriuretic peptide; ECG, electrocardiogram; HDL, high-density lipoprotein; LDL, low-density lipoprotein; UACR, the ratio of urinary albumin to urinary creatinine (mg per g creatinine).
Pulse wave velocity and cardiac and renal damage H Sonoda et al Sclerotic changes in central arteries are one of the main determinants of PWV. Thus, it is not surprising that factors that may modify functional or structural characteristics of the arterial wall have a certain influence on baPWV values. Indeed, univariate analysis revealed correlations between baPWV and age, LDLcholesterol, blood pressure and fasting plasma glucose. However, multivariate analysis revealed that the lipid profile and glucose tolerance were not independent determinants of baPWV values, indicating that age and blood pressure have a powerful impact on baPWV. Of note, the ECG voltage and UACR levels showed independent correlations with the baPWV value after adjustment for established risk factors. This indicates that the baPWV value reflects organ damage caused by a chronic increase in blood pressure, though this index is also affected by blood pressure levels at measurement.
The mechanism underlying the close relationship between cardiac and renal damage associated with a chronic increase in blood pressure and baPWV is not clear. Increased aortic stiffness causes the premature return of reflected waves in late systole and thus, causes an augmentation of central aortic pressure that may be closely related with left ventricular load. 12 This may partly explain the close relationship between the ECG voltage and baPWV. Moreover, increased aortic stiffness results in pressurerelated vascular damage in the renal circulation, which may cause glomerular hyperfiltration and albuminuria. As endothelial dysfunction may underlie urinary albumin excretion 13 and increased arterial stiffness, 14 this may be another pathophysiological link between urinary albumin and baPWV. Alternatively, sclerotic changes in the arterial tree may develop in parallel with target organ damage.
Several groups have reported a close relationship between increased arterial stiffness and urinary excretion of albumin. 15 --18 Microalbuminuria is associated with increased baPWV in the general population, 16 and an increase in baPWV predicts the development of microalbuminuria in patients with hypertension. 18 The present findings are consistent with these previous studies and have extended them to a population with normal albuminuria. This is quite important in the clinical setting, because urinary albumin excretion, even at levels below clinically defined thresholds for microalbuminuria, is associated with an increased incidence of cardiovascular and all-cause mortality. 19, 20 In addition, reduction of albuminuria under antihypertensive treatment is paralleled by changes in coronary vascular risk. 21, 22 Strikingly, salt intake adjusted for body weight was also a significant independent predictor of the baPWV value. Excess salt intake may accelerate atherosclerotic changes independently of its effects on blood pressure. Indeed, previous studies have reported that salt is an independent risk factor for stroke. 23, 24 The findings of the present study suggest that the measurement of baPWV may have potential as a new procedure in the management of hypertension and as a new risk marker in the general population. In the present study, baPWV was also positively correlated with heart rate, confirming the findings from a previous study. 25 This may be partly attributable to a change in the distensibility of large elastic arteries caused by an elevated heart rate. 26 We also confirmed the results of another study that showed a significant independent correlation between PWV and uric acid. 27 The close relationship between baPWV and uric acid observed in the present study supports the theory that uric acid is a marker of cardiovascular events, 28 although this is controversial. 29 Carotid-femoral PWV has been accepted as a standard method to evaluate aortic stiffness, and evidence is accumulating that an increased carotid-femoral PWV measurement is associated with increased cardiovascular morbidity and mortality. 4, 5, 30 baPWV, a new measure of arterial stiffness, provides qualitatively similar information to that obtained from aortic PWV, an index of central arterial stiffness, 31 although the baPWV value reflects a combination of elastic and muscular arterial stiffness. Sclerotic changes in peripheral muscular arteries may also be a risk factor associated with cardiovascular disease. Indeed, baPWV has been reported to be a better marker of cardiac load than carotid-femoral PWV. 32 Previous studies have demonstrated that baPWV predicts cardiovascular events in individuals at high risk, including those with acute coronary syndrome, 33 the elderly, 34 those on hemodialysis 35 and those with coronary artery disease. 36 We have further extended the clinical significance of baPWV by showing that this index provides important information for the screening of low-to-moderate risk individuals.
Interpretation of the present data is limited by the following conditions. Measurement of baPWV is based on a calculation using an indirect estimation of the distance between the brachium and ankle, and reflects stiffness of both elastic and muscular arteries, which may behave differently under various conditions. Also, the number of subjects studied was not large enough to draw definite conclusions. These points should be noted when interpreting the present data, and the results of the present cross-sectional study should be confirmed by a future longitudinal study.
In conclusion, baPWV showed independent correlations with individual salt intake, as well as cardiac and renal damage that is closely associated with a chronic increase in blood pressure, and thus, could be a useful procedure for identifying individuals with concealed risk of cardiovascular disease.
What is known about topic
Although the assessment of conventional risk factors is useful, these may not accurately estimate the risk of developing cardiovascular disease. An increase in carotid-femoral pulse wave velocity (PWV), a standard method to evaluate aortic stiffness, is associated with increased cardiovascular morbidity and mortality. Recently, a semi-automated device for the measurement of brachial-ankle PWV (baPWV), which reflects a combination of elastic and muscular arterial stiffness, was developed.
What this study adds
The baPWV value is independently associated with individual salt intake, as well as cardiac and renal damage that are closely associated with a chronic increase in blood pressure. baPWV is a useful procedure for identifying individuals with a concealed risk of cardiovascular disease.
